NCT04258449 - DOvEEgene Fleur: New Uterine Sampling Tool | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 11, 2020

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions

Women With Suspected or Confirmed Gynecological Disease

Interventions

DEVICE

DOvEEgene Fleur Sampling

Patients will undergo uterine sampling with DOvEEgene Fleur endometrial sampling device prior to surgical intervention, in addition to standard of care treatment.

Trial Locations (1)

H4A 3J1

RECRUITING

Royal Victoria Hospital (Glen Site), Montreal